Overview
Glycerol kinase deficiency (GKD), also known as hyperglycerolemia, is a rare X-linked metabolic disorder caused by mutations or deletions in the GK gene located on chromosome Xp21.2. Glycerol kinase is an enzyme that catalyzes the phosphorylation of glycerol to glycerol-3-phosphate, a key step in fat metabolism and gluconeogenesis. Deficiency of this enzyme leads to accumulation of glycerol in the blood (hyperglycerolemia) and urine (glyceroluria). The condition predominantly affects males. GKD presents in several clinical forms. The infantile (or complex) form often results from a contiguous gene deletion syndrome involving the GK gene along with neighboring genes, including the DAX1 gene (causing adrenal hypoplasia congenita) and the dystrophin gene (causing Duchenne muscular dystrophy). Patients with this complex form may present with adrenal insufficiency, which can be life-threatening in the neonatal period, along with progressive muscular dystrophy, developmental delay, and intellectual disability. The juvenile form typically presents with developmental delay, behavioral issues, and metabolic acidosis. The benign or adult form may be asymptomatic and is often discovered incidentally through elevated triglyceride readings on laboratory testing (pseudohypertriglyceridemia), as glycerol is measured in some triglyceride assays. Treatment is primarily supportive and depends on the clinical form. Patients with the complex form require glucocorticoid and mineralocorticoid replacement therapy for adrenal insufficiency, and management of muscular dystrophy follows standard protocols. Dietary management with a low-fat diet may be recommended. Metabolic crises, including hypoglycemia and metabolic acidosis, require prompt medical intervention. Genetic counseling is important for affected families. Prognosis varies significantly depending on the form of the disease, with the isolated benign form having an excellent outlook and the complex form carrying more significant morbidity.
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Glycerol kinase deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Glycerol kinase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Glycerol kinase deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Glycerol kinase deficiency.
Community
No community posts yet. Be the first to share your experience with Glycerol kinase deficiency.
Start the conversation →Latest news about Glycerol kinase deficiency
No recent news articles for Glycerol kinase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Glycerol kinase deficiency
What is Glycerol kinase deficiency?
Glycerol kinase deficiency (GKD), also known as hyperglycerolemia, is a rare X-linked metabolic disorder caused by mutations or deletions in the GK gene located on chromosome Xp21.2. Glycerol kinase is an enzyme that catalyzes the phosphorylation of glycerol to glycerol-3-phosphate, a key step in fat metabolism and gluconeogenesis. Deficiency of this enzyme leads to accumulation of glycerol in the blood (hyperglycerolemia) and urine (glyceroluria). The condition predominantly affects males. GKD presents in several clinical forms. The infantile (or complex) form often results from a contiguous
How is Glycerol kinase deficiency inherited?
Glycerol kinase deficiency follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.